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Key Clinical Message
The restrictive lung disease can be exacerbated by growing fundus in women
with osteogenesis imperfecta type III. Regional anesthesia can be performed in
these women. Mode of delivery for women with osteogenesis imperfecta type
III is generally cesarean delivery. Neonatal outcomes are complicated due to
indicated preterm deliveries.
Keywords
Osteogenesis imperfecta, preterm delivery, restrictive lung disease, skeletal
deformity.
Introduction
Osteogenesis imperfecta (OI) is a rare inherited connec-
tive tissue disease. We present two pregnancies of a
patient with OI Type III, with severe scoliosis, and restric-
tive lung disease whose pregnancies were complicated by
frequent admissions for pneumonia and respiratory dis-
tress, resulting in iatrogenic preterm delivery.
Osteogenesis imperfecta (OI) is a rare inherited disease
of connective tissue that primarily involves the abnormal
synthesis of collagen, consisting of bone and many other
connective tissues [1]. OI is known as “Brittle bone dis-
ease,” which occurs when collagen is made of insufficient
quality or quantity. The clinical phenotype is broad and
ranges from a mild type (moderate increase in fracture
frequency) to a severe type (lethal in the perinatal
period).
Several cases of OI in pregnancy have been emphasiz-
ing the importance of the skeletal abnormalities in the
pregnant female. Complications reported in the literature
include pelvic contractures that lead to cesarean delivery,
an increased basal metabolic rate leading to hyperthermia,
and uterine rupture in labor [2–5].
Case History/Examination
Maternal medical history
We present two consecutive pregnancies of a patient
who had the common manifestation of type III OI,
kyphoscoliosis, leading to respiratory complications.
Maternal DNA sequence analysis for type 1 collagen
genes (COL1A1 and COL1A2), revealed a single nucleo-
tide substitution in one allele of the COL1A1 gene
(c.2596G>A) consistent with OI type III (Fig. 1) [6].
Her medical history was significant for skeletal deformi-
ties secondary to multiple long bone fractures. She was
wheelchair bound, had blue sclera, contracted hips and
pelvis, severe scoliosis with distortion of the chest (right
breast rotated anteriorly to mid-chest), lordosis limiting
abdominal expansion, and marked anterior bowing of
the tibias (Fig. 2). The patient also suffered from
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restrictive lung disease due to severe kyphoscoliosis
(Fig. 3) with associated chest wall deformities and sev-
ere asthma. She has had multiple admissions during
her lifetime for recurrent pneumonia. Her longtime
steroid use (Prednisone 10 mg daily) for lung disease
caused her to suffer from steroid induced diabetes mel-
litus. Maternal-fetal medicine physicians followed both
of her pregnancies.
Pregnancy No. 1
She initially presented at 8 weeks’ gestation for prenatal
care when she was 23 years old. Her height, weight, and
body mass index (BMI kg/m2) were 96 cm, 25 kg, and
27.1 kg/m2, respectively (Fig. 4). She had a mediport
placed the year prior due to a prolonged hospital course
secondary to pneumonia and difficulty swallowing tablets.
On physical examination, she was noted to be very short
stature. She measured 17 cm from her iliac crest to her
C-7 prominence. Auscultation of her lungs was unre-
markable and oxygen saturation was 97% on room air. A
previous chest radiograph was available for review, show-
ing severe scoliosis (Fig. 5).
Her first trimester screening with nuchal translucency
(Down syndrome 1 in 999 [background risk], <1 in
10,000 [screening risk]; Trisomy 18 1 in 1956 [back-
ground risk], <1 in 10,000 [screening risk]), infection
screening (hepatitis, human immunodeficiency virus, and
syphilis), hematologic and coagulation studies were within
normal limits. Chorionic villus sampling performed at
14 weeks’ gestation revealed a fetus unaffected by OI. A
maternal echocardiogram was within normal limits.
Detailed anatomy scan was performed at 22 weeks’ gesta-
tion by maternal-fetal medicine physician at our tertiary
care center, showing normal anatomy. At our institution,
ultrasound scans are performed according to ISUOG
(International Society of Ultrasound in Obstetrics and
Gynecology) guidelines.
As the patient’s pregnancy progressed, continuing
fetal growth further restricted her pulmonary capacity.
She progressively had positional dyspnea and inability
to sleep in the supine position. Bilevel positive airway
pressure (BPAP) at night and O2 via nasal cannula
during the day were started but only provided tempo-
rary relief. At 27 weeks’ gestation, the patient presented
again to the emergency room extremely agitated by her
progressive dyspnea. Tachypnea was noted on presenta-
tion with a respiratory rate of 30–40 breaths per
Figure 1. Diagram of the COL1A1 exons. The blue arrow points to the mutation our patient had in one allele of the COL1A1 gene (c.2596G>A)
at exon 38.
Figure 2. Severe anterior bowing of tibias.
Figure 3. Severe kyphoscoliosis.
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minute. An arterial blood gas revealed a pH of 7.41,
pCO2 of 32 mm of Hg, pO2 of 179 mm of Hg, and
bicarbonate of 20 mmol/L. In consultation with pul-
monary medicine, no evidence was present to suggest
an acute infectious process. Her symptoms were due to
her worsening restrictive lung disease secondary to the
gravid uterus.
A panel of pulmonary medicine, neonatology, anesthe-
sia, maternal-fetal medicine, and ethics providers met to
discuss the challenges of ongoing pregnancy in this com-
plicated patient and any potential delivery complications.
Risks associated with preterm delivery such as respiratory
distress syndrome, retinopathy, bronchopulmonary dys-
plasia, sepsis, necrotizing enterocolitis, intraventricular
hemorrhage, hypoglycemia, hyperbilirubinemia, impaired
cognitive skills, cerebral palsy, and sensory impairment
including vision and hearing losses were discussed with
the patient. The consensus was that delivery was indicated
based on a concern over potential respiratory collapse
with the recommendation for cesarean delivery at
28 weeks’ gestation after administration of a course of
betamethasone 12 mg. A regional anesthetic was recom-
mended, via fluoroscopy if needed, in order to avoid any
of the numerous complications anticipated with a general
anesthetic. Concern was raised for securing an airway in a
patient with a reduced range of motion of cervical spine
movement, poor dentition, and who was prone to frac-
tures and malignant hyperthermia.
The patient underwent cesarean section at 28 weeks’
gestation under epidural anesthesia. Before regional
anesthesia was attempted, direct laryngoscopy under
topical anesthesia of the oral pharynx was performed to
assess ease of intubation should a regional block fail or
ascend too high as to cause respiratory insufficiency.
The anesthesia provider was able to successfully place a
regional anesthetic using bupivacaine without the use of
fluoroscopy. Foam padding was required to ensure neu-
tral positioning of her limbs and support the angula-
tion of her pelvis (Fig. 6). Once positioned, it was
apparent that her lower abdomen was not well exposed.
A classical cesarean section was performed through a
transverse infra-umbilical skin incision (Fig. 7) with the
delivery of an infant female that weighed 970 g with
APGAR score of 4 and 7 after 1 and 5 min, respec-
tively. The umbilical artery blood gas showed pH 7.30,
bicarbonate 24.6 mmol/L, and base excess 0.0 mEq. The
neonate stayed in the neonatal intensive care unit for
71 days. She did have respiratory distress syndrome and
bronchopulmonary dysplasia but did not have compli-
cations of retinopathy, sepsis, necrotizing enterocolitis,
or intraventricular hemorrhage. She was discharged
home. The patient experienced a blood loss of 750 mL.
Considering her short stature, this was an interpreted
as a significant percentage of her total blood volume.
She received one unit of packed red blood cells intra-
operatively. Patient-controlled analgesia (PCA) with
hydromorphone was used for pain control until postop-
erative day 1. In the immediate postoperative period,
the patient reported a marked improvement in her
comfort and respiratory status. She no longer required
any supplemental oxygen. The patient had the appro-
priate return of bowel and bladder function and was
discharged home on postoperative day five. Prior to
discharge, a subcutaneous progesterone implant was
placed in her arm for contraception.
Figure 4. The external appearance of the patient with type III
osteogenesis imperfecta.
Figure 5. Chest radiograph. Chest radiograph showing severe
scoliosis.
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Pregnancy No. 2
Three years later, she presented at 8 weeks’ gestation for
prenatal care. Her height, weight, and BMI were 81 cm,
27.2 kg, and 41.5 kg/m2, respectively. Her restrictive lung
disease was worse, requiring home BPAP. She had anti-
Kell antibody (1:8), which she did not have in the previ-
ous pregnancy. Paternal genetic testing was declined.
Middle cerebral artery Doppler was performed and was
within normal limits until delivery. Her prenatal labs
included normal first trimester screening with nuchal
translucency (Down syndrome 1 in 905 [background
risk], <1 in 10,000 [screening risk]; Trisomy 18 1 in 1,633
[background risk], <1 in 10,000 [screening risk]). Amnio-
centesis was performed which showed 46,XX and no
COL1A1 mutation. A maternal echocardiogram was
within normal limit.
Her first trimester was complicated by hyperemesis
gravidarum requiring two hospital admissions and uri-
nary tract infection (UTI). Since 19 weeks’ gestation, she
started to feel shortness of breath, which was much earlier
than previous pregnancy. Her worsening respiratory
distress was thought to be growing the uterine size and
limited pulmonary capacity because of her worsening sev-
ere scoliosis. She was 15 cm shorter with the second preg-
nancy. Detailed anatomy scan was performed at 21 weeks’
gestation by maternal-fetal medicine physician at our ter-
tiary care center, showing normal anatomy. At 22 weeks’
gestation, she presented with worsening shortness of
breath and frequent contractions. She was diagnosed with
pneumonia. She declined admission and was discharged
with ceftriaxone 1 g IV daily through her mediport.
At 24 weeks’ gestation, she presented with respiratory
distress. Her respiratory rate was 50 and oxygen satura-
tion was 85%. Respiratory therapist and pulmonologist
were consulted. She was treated with oxygen by nasal can-
nula, nebulizer therapy every 6 h, and corticosteroid inha-
ler in addition to BPAP. Chest X-ray did not show
evidence of pneumonia. She also started to have frequent
painful uterine contractions. The digital cervical exam
was performed, showing no cervical dilation. However,
due to her pelvic anatomy displacement, her cervix was
difficult to access. Due to her worsening respiratory dis-
tress, early delivery was thought to be imminent. She
received a course of betamethasone 12 mg.
At 25 weeks’ gestation, she became progressively fati-
gued from her work of breathing. Early delivery at
27 weeks’ gestation after the second course of betametha-
sone was planned. As her previous pregnancy, the discus-
sion was made with pulmonologists, anesthesiologists,
neonatologists, and ethics providers. Risks of prematurity
were discussed with her as the previous pregnancy. Regio-
nal anesthesia was recommended. Because of possible dif-
ficult anesthesia, respiratory complications, and risk of
bleeding, the patient made an advance directive.
On the day of cesarean delivery, she received magne-
sium for neuroprophylaxis (6-gram bolus followed by 2 g
per hour). Epidural placement was tried twice without
success. Spinal anesthesia with bupivacaine was successful.
The high classical uterine incision was made. A 730 g
baby girl with APGAR score of 3, 5, and 6 after 1, 5, and
10 min, respectively, was delivered. The umbilical artery
blood gas showed pH 7.20, bicarbonate 11.6 mmol/L, and
base excess 0.0 mEq. The neonate did not have sepsis or
necrotizing enterocolitis. She had respiratory distress syn-
drome and bronchopulmonary dysplasia. In addition, she
had grade 3 right intraventricular hemorrhage and grade
4 left intraventricular hemorrhage. She stayed in the
neonatal intensive care unit for 99 days. During her stay,
she did not have seizures or shunt procedure. However,
she was transferred to another institution for further neu-
rological work-up.
Cesarean section was completed with a blood loss of
700 mL, which required one unit of red blood cell. She
underwent bilateral tubal ligation as she wished. Again,
Figure 6. Patient positioning and padding at time of cesarean
delivery.
Figure 7. Infra-umbilical skin incision.
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PCA with hydromorphone was used for pain control until
postoperative day 1. Her respiratory status dramatically
improved postoperatively. She was discharged on postop-
erative day nine.
Discussion
The most common cause of OI is gene mutations encod-
ing alpha-1 and alpha-2 chains of type 1 collagen or pro-
teins modifying type 1 collagen. Type 1 collagen is an
important structure for bone, tendon, ligament, skin, and
sclera. A common presentation of OI includes brittle
bones, short stature, scoliosis, hearing loss, and blue
sclera.
Sillence et al. [7] proposed four types of clinical classi-
fication. Type I is the most common and mildest form
with a variable fracture rate. Patients with type I OI usu-
ally have minimal deformity and normal stature, and
often have a hearing impairment. Type II OI is lethal in
uterus or shortly after birth. Typical causes of death
include severe fractures and pulmonary failure. Type III,
which this patient suffered from, is most severe form and
patients have marked deformity of the limbs and marked
kyphoscoliosis, thorax deformity, and significant short
stature. Type III OI is a rare disease with an incidence of
1/70,000 and there are few case reports of maternal type
III OI [4, 5, 7]. Distortion of spine and thorax can lead
to restrictive lung disease and sleep apnea syndrome. Pul-
monary insufficiency is a leading cause of death in
patients with type III OI. Patient with type IV OI have
mild to moderate bone fragility.
Fertility is preserved in patients with OI and there are
several case reports on maternal OI in pregnancy. Several
complications are reported, including respiratory insuffi-
ciency, difficult anesthesia management, pelvic pain,
increased risk of cesarean section and uterine rupture
[2–5].
Pulmonary insufficiency is the most common cause of
demise in Type II OI and affects a number of individuals
with the more severe Type III OI. This process may pro-
gress to pulmonary hypertension and subsequent cor pul-
monale, requiring oxygen support. Our case highlights
the respiratory complications of OI and how the growing
fundus exacerbated the restrictive lung disease. In this
patient, worsening respiratory condition was ultimately
the factor that led to her preterm delivery at 28 weeks’
gestation and 27 weeks’ gestation. Perhaps the occurrence
of respiratory complications at an earlier gestational age
was due to the worsening skeletal abnormalities and scol-
iosis over 3 years. The patient did lose 15 cm in height
during this time period.
Anesthesia for patients with OI presents challenges,
such as airway control, hemostasis, difficult insertion of
regional anesthesia, increased risk of perioperative hyper-
thermia, and respiratory insufficiency from the deformed
thoracic cavity. Airway management in patients with OI
can be challenging in terms of the difficult airway,
increased risk for odonto-axial dislocation, brittle teeth
and weak cervical and mandibular bones [4]. Higher risk
of perioperative hyperthermia has been reported [5]. This
case illustrates the successful use of regional anesthesia.
Successful use of regional anesthesia has been described
in patients with OI. Using regional anesthesia, we were
able to avoid tracheal intubation and its inherent risks of
aspiration and mandibular injury. General anesthesia
should be avoided whenever possible due to the potential
risk for malignant hyperthermia. In the event that the
regional block failed, precautionary measures were taken
to assess the ease of intubation should it be required.
Regional anesthesia may be challenging due to severe sco-
liosis, inability to tolerate the supine position awake, and
a preexisting coagulopathy.
Mode of delivery for patients with type III OI is gener-
ally cesarean delivery because of old maternal fractures
causing crippling skeletal deformities, cephalopelvic dis-
proportion, and increased incidence of abnormal presen-
tation [4, 5]. Other milder types of OI can be delivered
vaginally. However, in a retrospective study using diag-
nostic codes, women with OI (all types) had 6-fold
increased risk of cesarean delivery compared with women
without OI [8].
Conclusion
Management of maternal type III OI needs a multidisci-
plinary approach. Underlying restrictive lung disease
worsens as pregnancy progresses, which may mandate
early delivery. Mode of delivery is controversial, but many
patients with type III OI undergo cesarean delivery due to
skeletal deformities and malpresentation. Anesthesia can
be challenging, but successful regional anesthesia is
reported. Neonatal outcomes are complicated due to indi-
cated preterm deliveries.
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